We are live on ! Find out more
RPTP

Raptor Pharmaceutical
RPTP

Delisted

RPTP was delisted on the 24th of October, 2016.

74 hedge funds and large institutions have $359M invested in Raptor Pharmaceutical in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 20

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

4% more funds holding

Funds holding: 71 → 74 (+3)

4% more capital inflows, than outflows

Capital inflows: $32.3M | Capital outflows: $31M

9% less call options, than puts

Call options by funds: $19.1M | Put options by funds: $21M

Holders
74
Holders Change
+3
Holders Change %
+4.23%
% of All Funds
2.12%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
28
Reduced
20
Closed
11
Calls
$19.1​M
Puts
$21​M
Net Calls
-⁠$1.84​M
Net Calls Change
+$6.12​M

RPTP Hedge Fund Activity: Q2 2014 in Review

74 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Raptor Pharmaceutical (RPTP) for Q2 2014, worth a combined $359M — up 17% from $308M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new RPTP positions and 11 closed out — a net gain of 3 holders — while 28 added to existing stakes and 20 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $9.8M. The largest seller was Assured Investment Management, exiting entirely with an estimated $9.9M sold.

  • 74 institutional investors held Raptor Pharmaceutical (RPTP) as of Q2 2014, up from 71 in Q1 2014.
  • Funds reported $359M of Raptor Pharmaceutical stock for Q2 2014, up 17% quarter-over-quarter.
  • 14 funds opened new Raptor Pharmaceutical positions in Q2 2014 and 11 closed out, a net change of +3 holders.
  • The largest Raptor Pharmaceutical buyer in Q2 2014 was Goldman Sachs, an estimated $9.8M added.
  • The largest Raptor Pharmaceutical seller in Q2 2014 was Assured Investment Management, an estimated $9.9M sold.

Based on aggregated 13F filings for Q2 2014.